2-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-9-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4776316

PubChem CID: 162643342

Max Phase: Preclinical

Molecular Formula: C25H28N6O2

Molecular Weight: 444.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1ccc(C)cc1NC(=O)N2

Standard InChI:  InChI=1S/C25H28N6O2/c1-15-4-6-18-20(12-15)28-25(32)29-21-14-26-24(30-23(18)21)27-19-7-5-17(13-22(19)33-3)16-8-10-31(2)11-9-16/h4-7,12-14,16H,8-11H2,1-3H3,(H,26,27,30)(H2,28,29,32)

Standard InChI Key:  ABXLNTJIYQRHEA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   14.3820   -2.3525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3808   -3.1720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0889   -3.5810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0871   -1.9436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7988   -3.1729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7957   -2.3489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4408   -1.8269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2486   -2.0021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6100   -2.7456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2578   -3.4959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4526   -3.6837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2142   -4.4733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7798   -5.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5871   -4.8835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8218   -4.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7534   -1.3595    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6728   -3.5801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.6722   -4.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9640   -4.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9630   -5.6202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6709   -6.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3813   -5.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3788   -4.8026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6714   -6.8473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9612   -7.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9597   -8.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6658   -8.4787    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3751   -8.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3783   -7.2512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1488   -5.4771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2571   -4.3938    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2586   -3.5766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6632   -9.2959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 14 30  1  0
 19 31  1  0
 31 32  1  0
 27 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4776316

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.54Molecular Weight (Monoisotopic): 444.2274AlogP: 4.97#Rotatable Bonds: 4
Polar Surface Area: 91.41Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.57CX Basic pKa: 9.07CX LogP: 4.22CX LogD: 2.55
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.53Np Likeness Score: -0.87

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source